10x Genomics
271 hedge funds and large institutions have $4.98B invested in 10x Genomics in 2023 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 94 increasing their positions, 79 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1% less capital invested
Capital invested by funds: $5.03B → $4.98B (-$49.6M)
1.81% less ownership
Funds ownership: 92.63% → 90.82% (-1.8%)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
271
Holding in Top 10
5
Calls
$21M
Puts
$10.2M
Top Buyers
| 1 | +$208M | |
| 2 | +$59.6M | |
| 3 | +$41.1M | |
| 4 |
RI
RTW Investments
New York
|
+$29.8M |
| 5 |
Sands Capital Management
Arlington,
Virginia
|
+$21.4M |
Top Sellers
| 1 | -$272M | |
| 2 | -$58.2M | |
| 3 | -$46.4M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$37.8M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$28.4M |